24,486 Shares in Encompass Health Corporation $EHC Purchased by Man Group plc

Key Points

• Man Group plc acquired 24,486 Encompass Health shares worth approximately $2.475 million in the second quarter. Institutional investors collectively own 97.25% of the company.
• Encompass Health reported quarterly EPS of $1.55, beating estimates of $1.48, while revenue rose 9.6% year over year to $1.60 billion. The company issued fiscal 2026 EPS guidance of $6.02–$6.25.
• Analysts maintain a consensus “Buy” rating with an average price target of $148.71, while the company increased its quarterly dividend from $0.19 to $0.21 per share. Separately, the CEO and an executive vice president sold shares.

Man Group plc acquired a new stake in shares of Encompass Health Corporation (NYSE:EHC - Free Report) in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 24,486 shares of the company's stock, valued at approximately $2,475,000.

Several other institutional investors have also made changes to their positions in the company. Northwestern Mutual Wealth Management Co. raised its stake in Encompass Health by 3,059,159.7% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 3,793,482 shares of the company's stock valued at $402,640,000 after purchasing an additional 3,793,358 shares during the period. AlphaCore Capital LLC acquired a new stake in shares of Encompass Health in the fourth quarter worth $4,881,000. Ancora Advisors LLC purchased a new position in shares of Encompass Health during the second quarter valued at $10,639,000. Systematic Financial Management LP raised its position in Encompass Health by 3.6% during the fourth quarter. Systematic Financial Management LP now owns 440,752 shares of the company's stock valued at $46,782,000 after buying an additional 15,462 shares during the period. Finally, Trillium Asset Management LLC lifted its stake in Encompass Health by 5.7% in the 4th quarter. Trillium Asset Management LLC now owns 217,734 shares of the company's stock worth $23,424,000 after acquiring an additional 11,793 shares in the last quarter. 97.25% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In related news, EVP John Patrick Darby sold 8,906 shares of Encompass Health stock in a transaction on Monday, August 10th. The shares were sold at an average price of $125.95, for a total value of $1,121,710.70. Following the transaction, the executive vice president owned 75,041 shares in the company, valued at $9,451,413.95. This trade represents a 10.61% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Mark J. Tarr sold 173,148 shares of the company's stock in a transaction dated Monday, August 10th. The shares were sold at an average price of $125.47, for a total transaction of $21,724,879.56. Following the sale, the chief executive officer owned 267,814 shares of the company's stock, valued at $33,602,622.58. This trade represents a 39.27% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. 1.80% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

A number of research firms have recently issued reports on EHC. Wall Street Zen raised shares of Encompass Health from a "hold" rating to a "buy" rating in a research report on Sunday, August 16th. Weiss Ratings upgraded shares of Encompass Health from a "hold (c+)" rating to a "buy (b-)" rating in a research note on Wednesday, August 12th. Barclays increased their target price on shares of Encompass Health from $140.00 to $144.00 and gave the stock an "overweight" rating in a research report on Thursday, August 6th. Truist Financial upped their price target on shares of Encompass Health from $140.00 to $150.00 and gave the stock a "buy" rating in a research note on Friday, August 7th. Finally, Leerink Partners set a $152.00 price objective on Encompass Health in a report on Friday, May 22nd. One analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating and one has given a Hold rating to the stock. According to MarketBeat, the stock has a consensus rating of "Buy" and an average target price of $148.71.

Encompass Health Price Performance

NYSE EHC opened at $120.51 on Tuesday. Encompass Health Corporation has a fifty-two week low of $92.77 and a fifty-two week high of $127.99. The stock's 50-day moving average is $113.64 and its two-hundred day moving average is $107.27. The company has a debt-to-equity ratio of 0.76, a current ratio of 1.19 and a quick ratio of 1.19. The firm has a market cap of $11.89 billion, a P/E ratio of 19.63, a price-to-earnings-growth ratio of 2.45 and a beta of 0.72.

Encompass Health (NYSE:EHC - Get Free Report) last released its quarterly earnings results on Wednesday, August 5th. The company reported $1.55 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.48 by $0.07. Encompass Health had a return on equity of 18.08% and a net margin of 10.01%.The company had revenue of $1.60 billion during the quarter, compared to the consensus estimate of $1.57 billion. During the same quarter in the prior year, the company posted $1.40 EPS. The firm's revenue was up 9.6% on a year-over-year basis. Encompass Health has set its FY 2026 guidance at 6.020-6.250 EPS. On average, analysts anticipate that Encompass Health Corporation will post 6.08 earnings per share for the current fiscal year.

Encompass Health Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, October 15th. Shareholders of record on Thursday, October 1st will be issued a dividend of $0.21 per share. This represents a $0.84 annualized dividend and a yield of 0.7%. This is a boost from Encompass Health's previous quarterly dividend of $0.19. The ex-dividend date is Thursday, October 1st. Encompass Health's dividend payout ratio is 12.38%.

Encompass Health Company Profile

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.